Source: SKS Technologies [LinkedIn]
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • SKS Technologies Group (SKS) has received a formal acceptance of approximately $10 million to supply the audio visual package for the new Footscray Hospital, in Melbourne
  • It is to design, supply and install the Audio-Visual package related to the Private Public Partnership for the hospital
  • Construction of the $1.5 billion new Footscray Hospital is now underway
  • Matthew Jinks, CEO of SKS Technologies, says this formal acceptance is a significant achievement for the company
  • SKS Technologies Group Limited (SKS) last traded at $0.18 per share before market open on December 23

SKS Technologies Group (SKS) has received a formal acceptance of approximately $10 million to supply the audio visual package for the new Footscray Hospital, in Melbourne.

Construction of the $1.5 billion new Footscray Hospital is now underway, with SKS chosen to design, supply and install the Audio-Visual package related to the Private Public Partnership for the hospital.

The hospital will be the largest ever health infrastructure investment in Victoria’s history and is due to be completed in 2025.

Additional infrastructure will allow 15,000 more patients to be treated and almost 20,000 extra people to be seen in the emergency department each year.

There will also be a significant increase in mental health beds and more outpatient, palliative care, and surgical services.

Matthew Jinks, CEO of SKS Technologies, said this formal acceptance is a significant achievement for the company.

“Upon execution of the contract, expected to be in the early part of next year, the contract will place the company’s work in hand position in excess of $40 million and provides the business with a strong foundation for future growth and profits,” he said.

SKS Technologies Group Limited (SKS) last traded at $0.18 per share before market open on December 23.

SKS by the numbers
More From The Market Online

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Brian Leedman’s BlinkLab to join ASX: AI-driven smartphone app screens for autism, ADHD

BlinkLab is a world-first, AI-driven digital healthcare venture, that uses a smartphone and facial recognition to…

Osteopore stock spikes 900% on Singapore and Vietnam approvals

Osteopore's (ASX:OSX) share price was up 38% after the regenerative medicine company received approval for its…

Amplia Therapeutics takes step up in pancreatic cancer treatment

Amplia Therapeutics is on to next step in its pancreatic cancer treatment research after a successful…